ASX Share rice
Tue 18 May 2021 - 11:13:am (Sydney)

PAB Share Price

PATRYS LIMITEDPABPharmaceuticals, Biotechnology & Life Sciences

PAB Company Information

Name:

Patrys Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

100 Albert Road Melbourne VIC Australia 3205

Phone:

61 3 9692 7222

MD, CEO & Exec. Director:

Dr. James A. Campbell B.Sc., Ph.D., MBA

Company Sec.:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

VP of Bus. Devel. & Intellectual Property:

Dr. Deanne Greenwood B.Sc., GAICD, Ph.D., MBA

Company Overview:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited has a collaborative research program with Imagion Biosystems Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis. The company was founded in 2006 and is based in South Melbourne, Australia.

PAB Share Price Information

Shares Issued:

1.81B

Market Capitalisation:

$41.68M

Revenue (TTM):

$866.99K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.0028

Operating Margin (TTM):

$-3.51

Return On Assets (TTM):

$-0.18

Return On Equity (TTM):

$-0.31

Quarterly Revenue Growth (YOY):

0.781

Gross Profit(TTM):

$772.84K

Diluted Earnings Per Share (TTM):

$-0.002

PAB CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$-201,941

Net Income:

$-2,748,539

Total Cash From Operating Activities:

$-2,495,525

Depreciation:

$47.79K

Change To Account Receivables:

$60.59K

Capital Expenditures:

$0

PAB Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-2,748,540

Net Income:

$-2,748,540

Gross Profit:

$27.50K

Operating Income:

$-2,748,540

Total Revenue:

$772.84K

PAB Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$528.75K

Total Liabilities:

$498.38K

Total Stockholder Equity:

$4.88M

Other Current Liabilities:

$235.28K

Total Assets:

$5.38M

Common Stock:

$67.09M

Other Current Assets:

$182.91K

Retained Earnings:

$-63,461,445

Other Liabilities:

$24.95K

Cash:

$3.98M

Total Current Liabilities:

$473.44K

Property - Plant & Equipment:

$3.60K

Net Tangible Assets:

$4.35M

Total Current Assets:

$4.84M

Net Receivables:

$679.96K

Short-Term Investments:

$532.35K

Accounts Payable:

$77.97K

Short-Term Investments:

$532.35

Non Current Liabilities Total:

$24.95K

PAB Share Price History

PAB News

06 Jan, 2021
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
09 Oct, 2020
This article will reflect on the compensation paid to James Campbell who has served as CEO of Patrys Limited (ASX:PAB...
18 May, 2020
It hasn't been the best quarter for Patrys Limited (ASX:PAB) shareholders, since the share price has fallen 28% in...